Related Experiment Video
Updated: Feb 15, 2026
09:55
Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis
Published on: October 25, 2024
1.6K
[Studies on the pathogenesis of atherosclerosis]
Summary
SMC senescence, characterized by reduced proliferation and increased lipid accumulation, may significantly contribute to atherosclerosis development. This aging process in smooth muscle cells plays a crucial role in arterial wall changes.
Area of Science:
- Cardiovascular Research
- Cell Biology
- Pathogenesis Studies
Context:
- Atherosclerosis (As) is a chronic inflammatory disease characterized by plaque buildup in arteries.
- Early endothelial cell (EC) injury and smooth muscle cell (SMC) proliferation are key events in atherogenesis.
- Proteoglycans (PG) play a complex role in the development of arterial lesions.
Purpose:
- To review studies on the pathogenesis of atherosclerosis.
- To investigate the role of SMC senescence in the development of As.
- To examine the changes in proteoglycan expression during atherogenesis.
Summary:
- Clinico-pathological studies indicate early coronary As lesions and prolonged stenosis leading to heart disease.
- Morphological studies in rats showed neointimal thickening and increased chondroitin sulfate (CS)-PG with intimal injury.
- In vitro studies revealed that senescent SMCs (T10) exhibit increased lipid accumulation and altered proteoglycan synthesis (dermatan sulfate-CS-PG) compared to younger SMCs (T4).
Impact:
- Findings suggest that smooth muscle cell senescence is a critical factor in the pathogenesis of atherosclerosis.
- Understanding SMC senescence provides new insights into potential therapeutic targets for preventing or treating arterial disease.
- This research highlights the dynamic changes in the arterial wall during atherogenesis, involving ECs, SMCs, and proteoglycans.
Related Concept Videos
01:26Atherosclerosis III: Management
451
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
451
01:30Atherosclerosis I: Introduction
1.2K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.2K
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
579
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
579
01:30Pulmonary Hypertension: Classification and Pathogenesis
673
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
673
01:20Asthma: Pathogenesis and Management
1.4K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.4K
01:23Cystic Fibrosis: Pathogenesis
896
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
896